← Leaderboards
Wai Wong
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsRetinaMicrogliaAge Related Macular DegenerationImageResponseMinocyclinePhotoreceptorsPhysiologyImmunePathogenesisInterestBlindnessRetinal DiseasesSignal TransductionRetinalInflammatoryApoptosisLabelPhotoreceptor DegenerationMouse ModelBehaviorMorphologyStructure
Grant awards (37)
Dynamic Imaging of Retinal Microglia$669,798
ZIA · FY2020 · EY · contact PI
Role of Microglia in the Retina in Retinal Diseases$444,582
ZIA · FY2020 · EY · contact PI
Dynamic Imaging of Retinal Microglia$941,880
ZIA · FY2019 · EY · contact PI
Role of Microglia in the Retina in Retinal Diseases$790,408
ZIA · FY2019 · EY · contact PI
Microglial Inhibition as a Therapeutic Strategy for Subretinal Hemorrhage$55,081
ZIA · FY2019 · EY · contact PI
Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular Degeneration$27,540
ZIA · FY2019 · EY · contact PI
Dynamic Imaging of Retinal Microglia$946,851
ZIA · FY2018 · EY · contact PI
Role of Microglia in the Retina in Retinal Diseases$761,834
ZIA · FY2018 · EY · contact PI
Microglial Inhibition as a Therapeutic Strategy for Subretinal Hemorrhage$217,667
ZIA · FY2018 · EY · contact PI
Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular Degeneration$81,625
ZIA · FY2018 · EY · contact PI
Role of Microglia in the Retina in Retinal Diseases$887,356
ZIA · FY2017 · EY · contact PI
Dynamic Imaging of Retinal Microglia$645,827
ZIA · FY2017 · EY · contact PI
Microglial Inhibition as a Therapeutic Strategy for Subretinal Hemorrhage$304,536
ZIA · FY2017 · EY · contact PI
Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular Degeneration$131,269
ZIA · FY2017 · EY · contact PI
Role of Microglia in the Retina in Retinal Diseases$816,045
ZIA · FY2016 · EY · contact PI
Dynamic Imaging of Retinal Microglia$606,130
ZIA · FY2016 · EY · contact PI
Microglial Inhibition as a Therapeutic Strategy for Subretinal Hemorrhage$225,659
ZIA · FY2016 · EY · contact PI
Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular Degeneration$26,239
ZIA · FY2016 · EY · contact PI
Role of Microglia in the Retina in Retinal Diseases$731,030
ZIA · FY2015 · EY · contact PI
Dynamic Imaging of Retinal Microglia$484,219
ZIA · FY2015 · EY · contact PI
Microglial Inhibition as a Therapeutic Strategy for Subretinal Hemorrhage$225,656
ZIA · FY2015 · EY · contact PI
Role of Microglia in the Retina in Retinal Diseases$744,333
ZIA · FY2014 · EY · contact PI
Dynamic Imaging of Retinal Microglia$412,171
ZIA · FY2014 · EY · contact PI
Microglial Inhibition as a Therapeutic Strategy for Subretinal Hemorrhage$315,190
ZIA · FY2014 · EY · contact PI
Dynamic Imaging of Retinal Microglia$874,650
ZIA · FY2013 · EY · contact PI
Microglial Inhibition as a Therapeutic Strategy for Subretinal Hemorrhage$212,753
ZIA · FY2013 · EY · contact PI
AMD Phenotype and Genotype Study$26,003
ZIA · FY2013 · EY · contact PI
Dynamic Imaging of Retinal Microglia$852,280
ZIA · FY2012 · EY · contact PI
Microglial Inhibition as a Therapeutic Strategy for Subretinal Hemorrhage$219,158
ZIA · FY2012 · EY · contact PI
Dynamic Imaging of Retinal Microglia$196,669
ZIA · FY2011 · EY · contact PI
Microglial Inhibition as a Therapeutic Strategy for Subretinal Hemorrhage$163,891
ZIA · FY2011 · EY · contact PI
The Age-Related Eye Disease Study 2 (AREDS2)$65,556
ZIA · FY2011 · EY · contact PI
Dynamic Imaging of Retinal Microglia$312,164
ZIA · FY2010 · EY · contact PI
The Age-Related Eye Disease Study 2 (AREDS2)$156,082
ZIA · FY2010 · EY · contact PI
Dynamic Imaging of Retinal Microglia$333,808
ZIA · FY2009 · EY · contact PI
The Age-Related Eye Disease Study 2 (AREDS2)$153,123
ZIA · FY2009 · EY · contact PI
Dynamic Imaging of Retinal Microglia$998,990
Z01 · FY2008 · EY · contact PI